文献速递主动脉疾病

开窗分支腔内修复肾旁及胸腹主动脉瘤后健康相关生活质量的前瞻性评估

Prospective assessment of health-related quality of life after endovascular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts.
PubMed 文献 · J Vasc Surg · 2018-10-24

这项前瞻性单中心研究纳入159例肾旁或胸腹主动脉瘤患者,采用开窗分支腔内修复术(F-BEVAR),用SF-36问卷在基线、6-8周、6个月和12个月评估生活质量。结果显示两组躯体组分评分(PCS)在术后6-8周显著下降,肾旁组12个月恢复至基线,而胸腹组未恢复且12个月PCS显著低于肾旁组;心理组分评分(MCS)无下降。

要点

  • F-BEVAR术后6-8周PCS显著下降,肾旁动脉瘤患者12个月恢复至基线,胸腹动脉瘤患者未恢复。
  • 胸腹主动脉瘤患者基线PCS较低,且12个月PCS显著低于肾旁动脉瘤患者(P < .001)。
  • 主要不良事件与6-8周PCS下降相关(P = .021),再干预对PCS或MCS无影响。

核心结论

  • 胸腹主动脉瘤患者基线躯体健康相关生活质量评分较低。
  • F-BEVAR术后两组PCS均显著下降,肾旁组12个月恢复至基线,胸腹组未恢复。
  • 肾旁动脉瘤患者生活质量变化与标准EVAR治疗肾下腹主动脉瘤相似。

研究设计与样本

  • 前瞻性、非随机、单中心研究,纳入159例连续患者(70%男性;平均年龄75 ± 7岁),2013-2016年使用定制开窗分支腔内移植物(F-BEVAR)。
  • 所有患者随访至少12个月(平均随访27 ± 12个月)。
  • 使用36项简短健康调查问卷(SF-36)在基线(N = 159)、6-8周(n = 136)、6个月(n = 129)和12个月(n = 123)评估健康相关生活质量。
  • 将PCS和MCS与EVAR 1试验中接受标准EVAR治疗简单肾下腹主动脉瘤患者的历史结果进行比较。

主要发现

  • 57例肾旁主动脉瘤(PAA)和102例胸腹主动脉瘤(TAAA)(50例IV型,52例I-III型)。
  • 无30天死亡、院内死亡、中转开放手术或主动脉相关死亡;1年生存率96%,2年生存率87%。
  • 主要不良事件发生率18%,1年再干预率14%。
  • 两组30天结局无统计学显著差异。
  • 胸腹主动脉瘤患者基线评分低于肾旁主动脉瘤患者(P < .05)。

临床怎么用

  • 应告知胸腹主动脉瘤患者F-BEVAR术后躯体生活质量可能持续下降至12个月且未恢复至基线。
  • 肾旁主动脉瘤患者术后躯体功能在12个月内可恢复至基线,预后咨询可相应调整。
  • 主要不良事件与早期PCS下降相关,术后早期需关注躯体功能恢复。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to investigate changes in health-related quality of life (QOL) in patients treated for pararenal aortic aneurysms (PAAs) and thoracoabdominal aortic aneurysms (TAAAs) with fenestrated-branched endovascular aneurysm repair (F-BEVAR). METHODS: A total of 159 consecutive patients (70% male; mean age, 75 ± 7 years) were enrolled in a prospective, nonrandomized single-center study using manufactured F-BEVAR (2013-2016). All patients were observed for at least 12 months (mean follow-up time, 27 ± 12 months). Patients' health-related QOL was assessed using the 36-Item Short Form Health Survey questionnaire at baseline (N = 159), 6 to 8 weeks (n = 136), 6 months (n = 129), and 12 months (n = 123). Physical component scores (PCSs) and mental component scores (MCSs) were compared with historical results of patients enrolled in the endovascular aneurysm repair (EVAR) 1 trial who were treated by standard EVAR for simple infrarenal abdominal aortic aneurysms. RESULTS: There were 57 patients with PAAs and 102 patients with TAAAs (50 extent IV and 52 extent I-III TAAAs). There were no 30-day deaths, in-hospital deaths, conversions to open surgery, or aorta-related deaths. Survival was 96% at 1 year and 87% at 2 years. Major adverse events occurred in 18% of patients, and 1-year reintervention rate was 14%. There were no statistically significant differences between the groups in 30-day outcomes. Patients treated for TAAAs had lower baseline scores compared with those treated for PAAs (P < .05). PCS declined significantly 6 to 8 weeks after F-BEVAR in both groups and returned to baseline values at 12 months in the PAA group but not in the TAAA group. Patients with TAAAs had significantly lower PCSs at 12 months compared with those with PAAs (P < .001). There was no decline in mean MCS. Major adverse events were associated with decline in PCS assessed at 6 to 8 weeks (P = .021) but not in the subsequent evaluations. Reinterventions had no effect on PCS or MCS. Overall, patients treated by F-BEVAR had similar changes in QOL measures as those who underwent standard EVAR in the EVAR 1 trial, except for lower PCS in TAAA patients at 12 months. CONCLUSIONS: Patients treated for TAAAs had lower scores at baseline in their physical aspect of health-related QOL. F-BEVAR was associated with significant decline in PCSs in both groups, which improved after 2 months and returned to baseline values at 12 months in patients with PAAs but not in those with TAAAs. Patients treated for PAAs had similar changes in QOL compared with those treated for infrarenal aortic aneurysms with standard EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kärkkäinen JM, Sandri GA, Tenorio ER, et al. Prospective assessment of health-related quality of life after endovascular repair of pararenal and thoracoabdominal aortic aneurysms using fenestrated-branched endografts. J Vasc Surg. 2018. PMID: 30714570. doi:10.1016/j.jvs.2018.07.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。